<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Fungal Biol.</journal-id>
<journal-title>Frontiers in Fungal Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Fungal Biol.</abbrev-journal-title>
<issn pub-type="epub">2673-6128</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/ffunb.2025.1613244</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Fungal Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Antagonistic effect of <italic>Pseudomonas aeruginosa</italic> on <italic>Candida auris</italic>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Macedo</surname>
<given-names>Ana Beatriz N.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Silva</surname>
<given-names>Daniele de Figuer&#xea;do</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3036353/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Medeiros</surname>
<given-names>Anthony G. J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3113939/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Freitas</surname>
<given-names>Gustavo Jos&#xe9;</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/980413/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santos</surname>
<given-names>Murilo Moreira dos</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ishida</surname>
<given-names>Kelly</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peres</surname>
<given-names>Nalu Teixeira de Aguiar</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/285290/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santos</surname>
<given-names>Daniel Assis</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/209436/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rossato</surname>
<given-names>Luana</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goldman</surname>
<given-names>Gustavo H.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/21309/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bastos</surname>
<given-names>Rafael Wesley</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/449740/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Departamento de Microbiologia e Parasitologia, Universidade Federal do Rio Grande do Norte</institution>, <addr-line>Natal, Rio Grande do Norte</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Departamento de Microbiologia, Universidade Federal de Minas Gerais, Belo Horizonte</institution>, <addr-line>Minas Gerais</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Departamento de Microbiologia, Universidade de S&#xe3;o Paulo</institution>, <addr-line>S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Instituto Nacional de Ci&#xea;ncia e Tecnologia</institution>, <addr-line>Ribeir&#xe3;o Preto, S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Laborat&#xf3;rio de Pesquisa em Ci&#xea;ncias da Sa&#xfa;de, Universidade Federal da Grande Dourados</institution>, <addr-line>Dourados, Mato Grosso do Sul</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto, Universidade de S&#xe3;o Paulo</institution>, <addr-line>Ribeir&#xe3;o Preto, S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Kevin K Fuller, University of Pittsburgh, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Ren&#xe1;t&#xf3; Kov&#xe1;cs, University of Debrecen, Hungary</p>
<p>Pedro Miramon, University of Texas Health Science Center at Houston, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Rafael Wesley Bastos, <email xlink:href="mailto:rafael.bastos@ufrn.br">rafael.bastos@ufrn.br</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>07</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>6</volume>
<elocation-id>1613244</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Macedo, Silva, Medeiros, Freitas, Santos, Ishida, Peres, Santos, Rossato, Goldman and Bastos</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Macedo, Silva, Medeiros, Freitas, Santos, Ishida, Peres, Santos, Rossato, Goldman and Bastos</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>
<italic>Candida (Candidozyma) auris</italic> and <italic>Pseudomonas aeruginosa</italic> are frequently found in hospital environments and on medical equipment, where they commonly colonize and infect hospitalized patients, contributing to healthcare-associated infections (HAIs). Although they share similar ecological niches and may interact, the mechanisms underlying their interspecies communication remain largely unknown.</p>
</sec>
<sec>
<title>Methods</title>
<p>This study investigated the <italic>in vitro</italic> interaction between planktonic cells of <italic>C. auris</italic> and <italic>P. aeruginosa</italic> through co-culture experiments in various growth media, with or without iron supplementation. Fluorescence microscopy was employed to assess yeast viability, and the effect of lyophilized, cell-free <italic>P. aeruginosa</italic> supernatants on <italic>C. auris</italic> was also evaluated.</p>
</sec>
<sec>
<title>Results</title>
<p>
<italic>P. aeruginosa</italic> significantly inhibited the growth of <italic>C. auris</italic>, regardless of the initial microbial concentrations. Growth suppression began after 8 hours of co-culture and persisted for up to 72 hours. Fluorescence microscopy suggested that this antagonistic effect was predominantly fungistatic, as most <italic>C. auris</italic> cells remained viable in the presence of the bacterium. The inhibitory effect was consistent across different culture media, and iron supplementation partially restored <italic>C. auris</italic> growth. Similarly, concentrated cell-free supernatants from <italic>P. aeruginosa</italic> inhibited <italic>C. auris</italic>, further supporting the role of secreted molecules. In this case as well, iron addition partially reversed the inhibitory effect.</p>
</sec>
<sec>
<title>Discussion and conclusion</title>
<p>These findings suggest that <italic>P. aeruginosa</italic> produces and secretes molecules with fungistatic activity against <italic>C. auris</italic>, and that this effect is at least partially modulated by iron availability. This discovery provides a foundation for future research into the identity and mechanisms of action of these secreted compounds, as well as the broader clinical implications of microbial interactions during co-colonization or co-infection.</p>
</sec>

</abstract>
<kwd-group>
<kwd>microbial interaction</kwd>
<kwd>healthcare-associated infections</kwd>
<kwd>fungistatic effect</kwd>
<kwd>iron</kwd>
<kwd>coculture</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="0"/>
<equation-count count="1"/>
<ref-count count="49"/>
<page-count count="15"/>
<word-count count="6388"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Fungal Physiology and Metabolism</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>First described in 2009 by Satoh and colleagues, <italic>Candida auris</italic>&#x2014;now renamed <italic>Candidozyma auris</italic>&#x2014;has rapidly emerged as a global threat due to its multidrug resistance and ability to persist in hospital environments (<xref ref-type="bibr" rid="B23">Lockhart et&#xa0;al., 2017</xref>). This yeast has been included in the World Health Organization (WHO) list of critical priority fungi, underscoring the urgent need for novel antifungal therapies and enhanced public health measures to prevent its spread (<xref ref-type="bibr" rid="B47">World Health Organization, 2022</xref>).</p>
<p>
<italic>C. auris</italic> transmission occurs primarily through direct contact in hospital settings, where it can colonize patients&#x2019; skin and persist in the environment, becoming a significant source of healthcare-associated infections (HAIs) (<xref ref-type="bibr" rid="B3">Alanio et&#xa0;al., 2022</xref>). Contaminated medical equipment and hospital surfaces&#x2014;particularly thermometers and stethoscopes (<xref ref-type="bibr" rid="B14">Govender et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B48">Yadav et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B10">Didik et&#xa0;al., 2023</xref>)&#x2014;have been identified as key vectors, with outbreaks often traced back to inadequate disinfection practices.</p>
<p>Microorganisms such as <italic>C. auris</italic> coexist with bacteria in human and hospital environments, forming complex and dynamic ecosystems (<xref ref-type="bibr" rid="B30">Peleg et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B34">Proctor et&#xa0;al., 2021</xref>). A noteworthy pathogen in healthcare settings is <italic>Pseudomonas aeruginosa</italic>, a highly antibiotic-resistant bacterium capable of long-term persistence in hospital environments, similar to <italic>C. auris</italic> (<xref ref-type="bibr" rid="B15">Grainha et&#xa0;al., 2020</xref>).</p>
<p>
<italic>P. aeruginosa</italic> is a Gram-negative, non-glucose fermenting, motile, oxidase-positive bacillus that thrives in a wide range of environments, from aquatic and terrestrial ecosystems to plants, animals, and humans (<xref ref-type="bibr" rid="B15">Grainha et&#xa0;al., 2020</xref>). It is notorious for its ability to form biofilms on abiotic surfaces, such as medical implants and industrial equipment, as well as within the human host, particularly in the respiratory tracts of individuals with cystic fibrosis (<xref ref-type="bibr" rid="B44">Thi et&#xa0;al., 2020</xref>). Although capable of infecting immunocompetent individuals, it is most prevalent in immunocompromised or hospitalized patients undergoing broad-spectrum antibiotic therapies, making it a leading cause of HAIs, often affecting the respiratory and urinary tracts, as well as the bloodstream (<xref ref-type="bibr" rid="B25">Mielko et&#xa0;al., 2019</xref>).</p>
<p>In this context, a case report of <italic>P. aeruginosa</italic> infection in a patient colonized by <italic>C. auris</italic> (<xref ref-type="bibr" rid="B34">Proctor et&#xa0;al., 2021</xref>) has been documented, along with metagenomic data showing that both microorganisms can colonize the skin of nursing home residents (<xref ref-type="bibr" rid="B35">Proctor et&#xa0;al., 2025</xref>). These findings suggest that <italic>P. aeruginosa</italic> may come in contact and directly interact with <italic>C. auris</italic> in hospital environments and/or within the host, potentially altering the dynamics of these pathogens in such settings.</p>
<p>Although the implications of the interaction between <italic>C. auris</italic> and <italic>P. aeruginosa</italic> are still poorly understood, emerging evidence suggests that <italic>P. aeruginosa</italic> exhibits antimicrobial and antibiofilm activities against a wide variety of other fungi, including <italic>Aspergillus fumigatus</italic> (<xref ref-type="bibr" rid="B5">Bastos et&#xa0;al., 2022</xref>), <italic>Cryptococcus</italic> spp. (<xref ref-type="bibr" rid="B31">Peres-Em&#xed;dio, 2020</xref>), and <italic>Candida albicans (</italic>
<xref ref-type="bibr" rid="B45">Trejo-Hern&#xe1;ndez et&#xa0;al., 2014</xref>). In the case of <italic>P. aeruginosa</italic>&#x2013;C<italic>. albicans</italic>, the interaction involves molecular communication mediated by compounds produced in response to mutual stimulation between the microorganisms. The yeast secretes ethanol, which induces <italic>P. aeruginosa</italic> to synthesize and release toxic phenazines. These phenazines, in turn, promote even greater ethanol production by <italic>C. albicans</italic>, resulting in the functional collapse of mitochondria (<xref ref-type="bibr" rid="B16">Greenberg et&#xa0;al., 1999</xref>; <xref ref-type="bibr" rid="B27">Morales et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B22">Lindsay et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B9">d&#x2019;Enfert et&#xa0;al., 2021</xref>). Furthermore, phenazines and other metabolites secreted by <italic>P. aeruginosa</italic> can interfere with iron homeostasis in <italic>C. albicans</italic> and other fungi, leading to growth arrest (<xref ref-type="bibr" rid="B36">Purschke et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B31">Peres-Em&#xed;dio, 2020</xref>; <xref ref-type="bibr" rid="B35">Proctor et&#xa0;al., 2025</xref>).</p>
<p>Given the complexity of these interaction and their potential impact on co-colonization, the goal of this study is to evaluate the <italic>in vitro</italic> interaction between <italic>C. auris</italic> and <italic>P. aeruginosa</italic>, in comparison with the interaction with <italic>C. albicans</italic>, to identify factors that may influence these dynamics.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Microorganisms</title>
<p>
<italic>C. auris</italic> isolates from different origins were used: <italic>C. auris</italic> 467/15 (Venezuela) (<xref ref-type="bibr" rid="B7">Calvo et&#xa0;al., 2016</xref>), <italic>C. auris</italic> 136/18 (South Africa) (<xref ref-type="bibr" rid="B24">Magobo et&#xa0;al., 2014</xref>), <italic>C. auris</italic> 139/18 (Spain) (<xref ref-type="bibr" rid="B38">Ruiz-Gait&#xe1;n et&#xa0;al., 2018</xref>), <italic>C. auris</italic> 138/18 (South Korea) (<xref ref-type="bibr" rid="B21">Lee et&#xa0;al., 2011</xref>), <italic>C. auris</italic> 140/18 (England) (<xref ref-type="bibr" rid="B41">Schelenz et&#xa0;al., 2016</xref>), and <italic>C. auris</italic> CBS 10913 (Japan) (<xref ref-type="bibr" rid="B40">Satoh et&#xa0;al., 2009</xref>). The reference strain <italic>C. albicans</italic> ATCC (American Type Culture Collection) 90028 and the clinical isolates of <italic>P. aeruginosa</italic> Pa14 (<xref ref-type="bibr" rid="B37">Rahme et&#xa0;al., 1997</xref>), Pa01 (<xref ref-type="bibr" rid="B26">Mikkelsen et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B46">Wettstadt et&#xa0;al., 2019</xref>), and Pak (<xref ref-type="bibr" rid="B39">Saliba et&#xa0;al., 2005</xref>) also were used. All strains were maintained in BHI medium (brain heart infusion; Kasvi, Brazil) supplemented with 10% glycerol at &#x2212;80&#xb0;C until use.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Interaction between <italic>C. auris</italic> and <italic>P. aeruginosa</italic> using the spot-on-the-lawn method</title>
<p>The spot-on-the-lawn antagonism method was performed according to <xref ref-type="bibr" rid="B17">Harris et&#xa0;al. (1989)</xref>, with the modifications introduced by <xref ref-type="bibr" rid="B32">Peres-Emidio et&#xa0;al. (2022)</xref>. Initially, 10 &#x3bc;L of <italic>P. aeruginosa</italic> Pa14, Pa01, and Pak (at 10<sup>6</sup> colony-forming units [CFU]/mL), previously grown for 16 hours in BHI at 37&#xb0;C, were spotted onto the center of Petri dishes containing BHI agar and incubated at 37&#xb0;C for 18 hours.</p>
<p>The bacterial cells were then inactivated with 1 mL of chloroform vapor added to the lids of each plate. After 30 minutes of incubation at room temperature, the plates were left uncovered until the chloroform completely evaporated. Subsequently, 3 mL of semi-solid YPD medium (1% yeast extract, 2% peptone, 2% dextrose, and 0.75% agar), with 1&#xd7;10<sup>5</sup> CFU/mL of either <italic>C. albicans</italic> ATCC90028 or <italic>C. auris</italic> 467/15, was poured over the solid BHI medium containing the inactivated bacterial spot. After incubation for 48 hours at 37&#xb0;C, the inhibition zones formed on the fungal cell lawn were visually measured. The <italic>C. auris</italic> and <italic>C. albicans</italic> cultures used in this assay were obtained from previous cultivation in YPD liquid medium for 24 hours.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Interaction between <italic>C. auris</italic> and <italic>P. aeruginosa</italic> using the co-culture in liquid medium method</title>
<p>Yeast inhibition was also evaluated in the co-cultivation of <italic>C. auris</italic> 467/15 with <italic>P. aeruginosa</italic> Pa14 in liquid medium (<xref ref-type="bibr" rid="B32">Peres-Emidio et&#xa0;al., 2022</xref>). Co-cultures and monocultures of <italic>C. auris</italic> and <italic>P. aeruginosa</italic> were prepared using different bacterial inocula (1&#xd7;10<sup>5</sup>, 10<sup>6</sup>, and 10<sup>7</sup> CFU/mL) and a fixed fungal inoculum of 1&#xd7;10<sup>5</sup> CFU/mL. The experiment was conducted in 1.5 mL tubes containing 1 mL of RPMI-1640 (Roswell Park Memorial Institute) medium (Gibco, USA) buffered with 34.5 g of MOPS (3-(N-morpholino) propanesulfonic acid) (Sigma-Aldrich, USA), with the pH adjusted to 7.0&#x2013;7.2.</p>
<p>After incubation at 37&#xb0;C for 24 hours, aliquots were plated on YPD medium with 0.2 mg/L of chloramphenicol. The plates were incubated at 37&#xb0;C for 48 hours for CFU counting. The results were expressed in log CFU/mL, comparing fungal growth in monocultures and co-cultures (<xref ref-type="bibr" rid="B31">Peres-Em&#xed;dio, 2020</xref>). The number of input cells in each case was similarly determined to ensure equivalent initial inocula of the bacterium and yeast.</p>
<p>As a control, the interaction between <italic>Candida albicans</italic> 90028 and <italic>P. aeruginosa</italic> Pa14 was included in all experiments, following the same protocol.</p>
<p>To broaden the findings obtained with the <italic>C. auris</italic> 467/15 strain, additional interaction assays in liquid medium were performed using <italic>C. auris</italic> isolates from diverse geographic origins: <italic>C. auris</italic> 136/18, 138/18, 139/18, 140/18, and CBS 10913. In these assays, a fungal inoculum of 1&#xd7;10<sup>5</sup> CFU/mL and a bacterial inoculum of 1&#xd7;10<sup>6</sup> CFU/mL of <italic>P. aeruginosa</italic> Pa14 were used.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Kinetics of the interaction between <italic>P. aeruginosa</italic> and <italic>C. auris</italic>
</title>
<p>A microbial kinetics experiment investigated the interaction between <italic>P. aeruginosa</italic> Pa14 and <italic>C. auris</italic> 467/15 over time. <italic>P. aeruginosa</italic> (1&#xd7;10<sup>6</sup> CFU/mL) was co-cultured with <italic>C. auris</italic> (1&#xd7;10<sup>5</sup> CFU/mL) in 1 mL of RPMI medium at 37&#xb0;C&#x2014;monoculture controls of each microorganism were also included. Samples were collected at 0, 4, 8, and 12 hours, and aliquots were plated on YPD agar supplemented with 0.2 mg/L chloramphenicol to determine yeast CFUs. To extend these findings, a subsequent experiment was conducted considering longer intervals: 0, 12, 24, 48, and 72 hours. At each time, aliquots were collected and plated to quantify bacterial CFUs on Cetrimide agar (Kasvi, Brazil) and yeast CFUs on YPD agar with 0.2 mg/L chloramphenicol.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>LIVE/DEAD staining by fluorescent microscopy</title>
<p>Cell viability resulting from the interaction between <italic>C. auris</italic> 467/15 or <italic>C. albicans</italic> ATCC 90028 and <italic>P. aeruginosa</italic> Pa14 was assessed via fluorescence microscopy, following a modified protocol based on <xref ref-type="bibr" rid="B43">Sun et&#xa0;al. (2016)</xref>. Co-cultures and monocultures were prepared in liquid RPMI medium as previously described, using inocula of 1&#xd7;10<sup>6</sup> CFU/mL for <italic>P. aeruginosa</italic> and 1&#xd7;10<sup>5</sup> CFU/mL for the fungi. After 72 hours of incubation at 35&#xb0;C, the microtubes were centrifuged, the supernatant was discarded, and 300 &#x3bc;L of LIVE/DEAD (SYTO 9/PI) fluorescent staining solution&#x2014;containing 5 &#x3bc;M SYTO 9 and 10 &#x3bc;g/mL propidium iodide (PI) (both from Invitrogen, USA), diluted in phosphate-buffered saline (PBS)&#x2014;was added to the pellet. This solution stains viable cells green (SYTO 9) and dead cells red (PI).</p>
<p>Samples were incubated with the stain for 30 minutes at 35&#xb0;C, protected from light. After that, the cells were washed twice with 300 &#x3bc;L of PBS, which was also used as the final resuspension volume. Finally, 20 &#x3bc;L of each sample was placed on a microscope slide, covered with a coverslip, and examined under a fluorescence microscope (EVOS FL Cell, USA).</p>
<p>Microscopic images from the co-culture and monoculture groups were processed using ImageJ software (<ext-link ext-link-type="uri" xlink:href="https://imagej.net/ij/">https://imagej.net/ij/</ext-link>) to quantify live cells. Transmitted light (Trans) images, captured without a fluorescence filter, were converted to 8-bit, followed by thresholding and post-thresholding refinement steps, and used for automatic cell counting. RGB images, generated from the fluorescence emitted by cells labeled with IP and SYTO 9, were processed by selecting the red and green channels to generate a composite image, in which automatic cell labeling and manual cell counting were performed.</p>
<p>Results were expressed as total cell count, number of live cells, and percentage of live cells. Total cell counts from monocultures (<italic>C. auris</italic> 467/15 or <italic>C. albicans</italic> ATCC 90028) and co-cultures (<italic>C. auris</italic> 467/15 + <italic>P. aeruginosa</italic> Pa14/<italic>C. albicans</italic> ATCC 90028 + <italic>P. aeruginosa</italic> Pa14) were obtained from images captured under transmitted light (no filter). The number of live cells was determined by subtracting the number of dead cells (PI-labeled) from the total cell count in each condition. This value was cross-validated by comparison with the number of SYTO 9-labeled cells (green fluorescence). The percentage of live cells was calculated using the formula:</p>
<disp-formula>
<mml:math display="block" id="M1">
<mml:mrow>
<mml:mtext>%&#xa0;live&#xa0;cells</mml:mtext>
<mml:mo>:</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mtext>total&#xa0;number&#xa0;of&#xa0;cells</mml:mtext>
<mml:mo>&#x2212;</mml:mo>
<mml:mtext>PI&#xa0;labeled&#xa0;dead&#xa0;cells</mml:mtext>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mo>&#xa0;</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mtext>total&#xa0;number&#xa0;of&#xa0;cells</mml:mtext>
</mml:mrow>
</mml:mfrac>
<mml:mtext>x&#xa0;</mml:mtext>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>
<p>All counts were performed on five replicates derived from three independent experimental groups (biological triplicates) for both monocultures and co-cultures.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Co-culture in different media</title>
<p>To investigate whether nutrient availability influences the bacterium-yeast interaction, co-cultures of <italic>P. aeruginosa</italic> Pa14 and <italic>C. auris</italic> 467/15, along with the respective controls, were performed in the following media: YPD, RPMI supplemented with 2% (w/v) glucose, 2-fold concentrated RPMI (RPMI 2x), and RPMI supplemented with FeSO&#x2084; (at 30, 120, 240, 480, 960, and 1920 &#x3bc;M). The results were compared with those obtained using standard RPMI, following the previously described liquid co-culture protocol, using a 10:1 bacterium-to-yeast ratio.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Cultivation of <italic>C. auris</italic> in cell-free supernatant from <italic>P. aeruginosa</italic> culture</title>
<p>
<italic>P. aeruginosa</italic> Pa14 was cultured individually for 24 or 72 hours at 37&#xb0;C. Following incubation, the cultures were centrifuged, and the supernatants were filtered through a 0.22 &#x3bc;m membrane to obtain the cell-free supernatant (CFS). The CFS was then mixed with RPMI in a 3:1 ratio (three parts CFS to one part 4-fold concentrated RPMI) and used to culture <italic>C. auris</italic> 467/15 at a final concentration of 1&#xd7;10<sup>5</sup> CFU/mL. As a control, <italic>C. auris</italic> was also cultured in a solution composed of three parts 0.85% NaCl (w/v) and one part 4-fold concentrated RPMI. After 24 hours of incubation at 37&#xb0;C, yeast cells were plated on YPD agar, and CFUs were counted and compared across treatment groups.</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Antifungal activity of lyophilized cell-free supernatant of <italic>P. aeruginosa</italic>
</title>
<p>
<italic>P. aeruginosa</italic> Pa 14 (1&#xd7;10<sup>6</sup> cells/mL) was cultured for 24 hours in 10 mL of RPMI medium at 37&#xb0;C. After incubation, the culture was centrifuged and filtered to obtain the CFS. The CFS and a control containing only RPMI were frozen and lyophilized for 48 hours, then reconstituted in 1 mL of RPMI. A portion of the reconstituted supernatant was supplemented with varying concentrations of ferrous sulfate (FeSO<sub>4</sub> at 30, 480, and 1920 &#x3bc;M). Subsequently, 100 &#x3bc;L of <italic>C. auris</italic> 467/15, adjusted to 1&#xd7;10<sup>5</sup> cells/mL, was added to 96-well plates with 100 &#x3bc;L of the reconstituted supernatant. The experimental groups comprised lyophilized cell-free supernatant (lCFS) of <italic>P. aeruginosa</italic> (lCFS<sub>Pa</sub>) and lCFS of <italic>P. aeruginosa</italic> supplemented with FeSO<sub>4</sub> (lCFS<sub>Pa</sub> + FeSO<sub>4</sub>). Lyophilized RPMI and fresh RPMI were used as growth control groups.</p>
<p>The plates were incubated at 37&#xb0;C, and visual assessments were conducted at 24, 48, and 72 hours. After 72 hours, aliquots from each experimental group were plated on YPD agar medium to quantify fungal viability.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Statistical data analysis</title>
<p>The results were subjected to statistical analysis using PRISM 8.0 software (GraphPad Inc., San Diego, CA, USA) to assess significant differences among the experimental groups. One-way or two-way ANOVA was applied, followed by Tukey&#x2019;s post-test or t-test at a 95% significance level. All experiments were performed independently at least three times.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>
<italic>P. aeruginosa</italic> inhibits <italic>C. auris</italic> growth similarly to <italic>C. albicans</italic>
</title>
<p>The interaction between <italic>C. auris</italic> and <italic>P. aeruginosa</italic> was analyzed using the spot-on-the-lawn method and co-cultivation in a liquid medium. The spot-on-the-lawn assay revealed inhibition zones caused by products secreted by <italic>P. aeruginosa</italic> strains (PA14, PAO1, and PAK), demonstrating that <italic>C. auris</italic> (467/15) is inhibited by this bacterium (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). The inhibition zones averaged 21.45 mm for strain PA14 (range = 20.4&#x2013;21.5 mm), 21.31 mm for PAO1 (19.1&#x2013;22.7 mm), and 21.19 mm for PAK (18.5&#x2013;20.6 mm) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). A similar effect was observed in the interaction with <italic>C. albicans</italic> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Inhibition of <italic>Candida</italic> spp. growth by <italic>P. aeruginosa</italic>. <bold>(A)</bold> Inhibition of <italic>Candida</italic> spp. growth observed in the spot-on-the-lawn assay with PA14, PAO1, and PAK. The images show the inhibition zone produced by each bacterium strain. <bold>(B)</bold> Inhibition zone measurements after interaction between <italic>P. aeruginosa</italic> and <italic>C</italic>. <italic>auris</italic> or <italic>C</italic>. <italic>albicans</italic>. Data are representative of three independent experiments.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="ffunb-06-1613244-g001.tif">
<alt-text content-type="machine-generated">Images show the interaction between Pseudomonas aeruginosa strains and Candida species. On the left, Petri dish images display inhibition zones for strains PA14, PAO1, and PAK against C. albicans and C. auris. On the right, a table lists the mean inhibition zones in millimeters with standard deviations. PA14 shows the largest inhibition zone for both Candida species, while PAK shows the smallest.</alt-text>
</graphic>
</fig>
<p>Although no statistically significant difference was detected among the bacterial strains (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>), <italic>P. aeruginosa</italic> PA14 was selected for the subsequent experiments, as it has been widely used in fungal interaction studies (<xref ref-type="bibr" rid="B31">Peres-Em&#xed;dio, 2020</xref>; <xref ref-type="bibr" rid="B5">Bastos et&#xa0;al., 2022</xref>).</p>
<p>Co-cultivation in a liquid medium was carried out to gain deeper insights into the phenomenon of antagonism. In the first step, varying concentrations of <italic>C. auris</italic> (10<sup>4</sup>, 10<sup>5</sup>, and 10<sup>6</sup> CFU/mL) were co-cultured with a fixed concentration of <italic>P. aeruginosa</italic> (1&#xd7;10<sup>6</sup> CFU/mL) in RPMI liquid medium. As shown in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>, <italic>P.&#xa0;aeruginosa</italic> significantly inhibited yeast growth&#x2014;by nearly 1 log cycle (10-fold) compared to <italic>C. auris</italic> grown in isolation&#x2014;regardless of the fungal inoculum concentration. Notably, the inhibition was most pronounced at the lowest yeast inoculum (10<sup>4</sup> CFU/mL). This result parallels the inhibitory effect observed for <italic>C. albicans</italic> when co-cultured with <italic>P. aeruginosa</italic> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>
<italic>Candida</italic> spp. inhibition by <italic>P. aeruginosa</italic> in a liquid medium. Growth of <italic>C</italic>. <italic>auris</italic> (Cau) <bold>(A)</bold> and <italic>C</italic>. <italic>albicans</italic> (Cal) <bold>(B)</bold> at different concentrations, in isolation and co-culture with <italic>P. aeruginosa</italic> (Pa). Growth of <italic>P. aeruginosa</italic> at different concentrations, in isolation and co-culture with <italic>C</italic>. <italic>auris</italic> <bold>(C)</bold> and <italic>C</italic>. <italic>albicans</italic> <bold>(D)</bold>. Data are representative of three independent experiments. Statistical analysis was performed using ANOVA followed by Tukey&#x2019;s post-test. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="ffunb-06-1613244-g002.tif">
<alt-text content-type="machine-generated">Bar graphs labeled A to D comparing fungal and bacterial inoculum. Graph A shows &#x201c;C. auris&#x201d; with different inoculum concentrations. Graph B depicts &#x201c;C. albicans&#x201d; with varying concentrations. Graphs C and D show &#x201c;P. aeruginosa&#x201d; with different inoculum levels. Statistically significant differences are indicated with asterisks.</alt-text>
</graphic>
</fig>
<p>Next, the yeast inoculum was kept constant (1&#xd7;10<sup>5</sup> CFU/mL) while the initial bacterial concentration varied (10<sup>5</sup>, 10<sup>6</sup>, and 10<sup>7</sup> CFU/mL). The results showed that higher bacterial inocula led to more significant inhibition of <italic>C. auris</italic> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>) and <italic>C. albicans</italic> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>).</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Co-cultivation with <italic>P. aeruginosa</italic> inhibits other <italic>C. auris</italic> strains</title>
<p>To investigate whether other <italic>C. auris</italic> isolates exhibit similar interaction behavior with <italic>P. aeruginosa</italic>, different <italic>C. auris</italic> strains were co-cultured in a liquid medium with the bacterium (1&#xd7;10<sup>5</sup> CFU/mL of yeast and 1&#xd7;10<sup>6</sup> CFU/mL of bacterium). Yeast concentrations were measured after 24 hours of co-cultivation.</p>
<p>
<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref> shows that the growth of all six <italic>C. auris</italic> strains (467/15, 136/18, 138/18, 139/18, 140/18, and CBS 10913) was significantly inhibited by <italic>P. aeruginosa</italic> compared to monoculture. This indicates that <italic>P. aeruginosa</italic> exerts a consistent antagonistic effect against multiple <italic>C. auris</italic> strains.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>
<italic>P. aeruginosa</italic> (Pa) consistently inhibited the growth of different <italic>C. auris</italic> strains (including 467/15). Data are representative of three independent experiments. Statistical analysis was performed using Student&#x2019;s t-test. ****p&lt;0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="ffunb-06-1613244-g003.tif">
<alt-text content-type="machine-generated">Bar chart showing the log CFU per mL for various samples, labeled 467/15, 467/15+Pa, 136/18, 136/18+Pa, 138/18, 138/18+Pa, 139/18, 139/18+Pa, 140/18, 140/18+Pa, CBS 10913, and CBS 10913+Pa. Each pair shows a significant difference marked by asterisks. Bars vary in color, indicating different sample groups.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Kinetics of <italic>C. auris</italic> inhibition by <italic>P. aeruginosa</italic>
</title>
<p>After demonstrating that <italic>P. aeruginosa</italic> consistently inhibits different <italic>C. auris</italic> strains during co-cultivation, additional experiments were performed using <italic>C. auris</italic> 467/15. First, the kinetics of the interaction were investigated to establish the time point of maximum inhibition. <xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4A, B</bold>
</xref> show a substantial negative effect of <italic>P. aeruginosa</italic> on <italic>C. auris</italic> growth, which became significant between 8 and 12 hours of co-cultivation.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Growth kinetics of <italic>C. auris</italic>, <italic>C. albicans</italic>, and <italic>P. aeruginosa</italic> in monoculture and co-culture. <italic>P. aeruginosa</italic> (Pa) significantly affected the growth of <italic>C. auris</italic> (Cau) and <italic>C. albicans</italic> (Cal) between 8 and 12 hours <bold>(A, B)</bold>. Growth inhibition persisted for up to 72 hours in both yeast species <bold>(C, D)</bold>. However, <italic>P. aeruginosa</italic> growth remained unaffected by the presence of either <italic>C. auris</italic> or <italic>C. albicans</italic> <bold>(E, F)</bold>. Statistical analysis was performed using a two-way ANOVA. ****<italic>p</italic>&lt;0.0001; ns, not significant (comparison between monoculture and co-culture at the same time points).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="ffunb-06-1613244-g004.tif">
<alt-text content-type="machine-generated">Graphs A to D show fungal load over time. Graphs A and B illustrate a significant increase in fungal load after twelve hours for Cau and Cal respectively, especially when combined with Pa. Graphs C and D show a significant reduction in fungal load for Cau + Pa and Cal + Pa over seventy-two hours. Graphs E and F show bacterial load with no significant changes for Pa and its combinations over seventy-two hours. Data points are marked with significance indicators such as &#x201c;ns&#x201d; and &#x201c;****&#x201d;.</alt-text>
</graphic>
</fig>
<p>Further analysis revealed that the inhibition of <italic>C. auris</italic> by <italic>P. aeruginosa</italic> persisted steadily throughout the 72-hour evaluation period, with no statistically significant changes over time (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). Interestingly, the fungal load in contact with the bacterium remained stable at approximately a 5-log cycle during the experiment (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). A similar pattern was observed for <italic>C. albicans</italic>, which exhibited comparable inhibition under the same conditions (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>). Moreover, no significant differences were observed in bacterial concentrations between monoculture and co-culture conditions with either <italic>C. auris</italic> (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>) or <italic>C. albicans</italic> (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>), indicating that these yeasts were unable to inhibit the bacterium growth significantly.</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Evaluation of the fungistatic effect of <italic>P. aeruginosa</italic> on <italic>C. auris</italic>
</title>
<p>As no significant changes in <italic>C. auris</italic> inhibition were observed over time during co-cultivation with <italic>P. aeruginosa</italic> from 12 to 72 hours (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>), we hypothesized that the bacterial effect might be fungistatic. To test this, <italic>C. auris</italic> and <italic>P. aeruginosa</italic> were cultured together and separately for 72 hours. The cells were then collected and stained with fluorescent markers to quantify total and live cells and calculate the live cell percentage.</p>
<p>A significant reduction in both total and live <italic>C. auris</italic> cell counts was observed in the co-culture with <italic>P. aeruginosa</italic> compared to monoculture (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A, B</bold>
</xref>). Additionally, a slight decrease in the percentage of live cells was detected (monoculture mean = 99.58% vs. co-culture mean = 97.67%) (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5C</bold>
</xref>). Notably, the number of <italic>C. auris</italic> cells in co-culture reduced to 36% compared to monoculture; yet, 97% of these cells remained live after 72 hours of co-cultivation with <italic>P. aeruginosa</italic>. This slight reduction in viability, in contrast to the pronounced decline in total and live cell counts, suggests that <italic>P. aeruginosa</italic> exerts a fungistatic rather than fungicidal effect on <italic>C. auris</italic>, as the majority of yeast cells remain alive but fail to proliferate in the presence of the bacterium (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A&#x2013;C</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>
<italic>P. aeruginosa</italic> exerts a fungistatic effect on <italic>Candida</italic> spp. LIVE/DEAD (SYTO9/PI) staining and fluorescence microscopy were performed after 72 hours of incubation. <bold>(A, D)</bold> Total cell counts of <italic>C. auris</italic> (Cau) or <italic>C. albicans</italic> (Cal) grown in monoculture or co-culture with <italic>P. aeruginosa</italic> (Pa), showing reduced fungal cell counts in the presence of the bacterium. <bold>(B, E)</bold> Live yeast cells (labeled with SYTO 9 and PI), highlighted after RGB image processing to quantify live and dead populations, also decreased under co-culture. <bold>(C, F)</bold> The percentage of live yeasts in monoculture versus co-culture indicates that, although total and live cell counts are reduced in the latter, the majority of cells remain live, indicating a fungistatic effect. Data are representative of three independent experiments. Statistical analysis was performed using Student&#x2019;s t-test. *<italic>p</italic>&lt;0.05; **<italic>p</italic>&lt;0.01; ***<italic>p</italic>&lt;0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="ffunb-06-1613244-g005.tif">
<alt-text content-type="machine-generated">Bar graphs comparing cell metrics between two conditions, Cau and Cau + Pa. Graphs A, B, and C show total cell count, live cell count, and percentage of live cells, respectively, with Cau having higher values. Graphs D, E, and F depict similar metrics for a likely different experiment, again showing higher values for Cau. Asterisks indicate statistical significance.</alt-text>
</graphic>
</fig>
<p>A similar experiment conducted with <italic>C. albicans</italic> yielded comparable results. After 72 hours, a reduction in both total and viable cell counts was evident, along with a slight decrease in the percentage of viable cells, further supporting a fungistatic effect under the influence of <italic>P. aeruginosa</italic> (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5D&#x2013;F</bold>
</xref>).</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>
<italic>C. auris</italic> growth inhibition by <italic>P. aeruginosa</italic> is consistent in different culture media</title>
<p>To evaluate whether different culture media and their compositions influence the interaction between <italic>C. auris</italic> and <italic>P. aeruginosa</italic>, we tested 2-fold concentrated RPMI, RPMI supplemented with 2% glucose, and liquid YPD, using standard RPMI as the reference condition. The inhibition of <italic>C. auris</italic> by <italic>P. aeruginosa</italic> remained consistent regardless of the medium used (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A&#x2013;C</bold>
</xref>). Moreover, the presence of additional nutrients, such as glucose in RPMI or the components of YPD, did not alter the inhibition pattern, showing no significant difference compared to the standard (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A&#x2013;C</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Growth inhibition of <italic>Candida</italic> spp. by <italic>P. aeruginosa</italic> is consistent across different media with varying nutritional compositions. <italic>C</italic>. <italic>auris</italic> (Cau) and <italic>C</italic>. <italic>albicans</italic> (Cal) were cultured alone or co-cultured with <italic>P. aeruginosa</italic> (Pa) in standard RPMI and compared with 2-fold RPMI <bold>(A)</bold>, RPMI + 2% glucose <bold>(B)</bold>, and YPD <bold>(C)</bold>. The results show that the bacterium inhibits yeast growth independently of the culture medium. Data are representative of three independent experiments. Statistical analysis was performed using Student&#x2019;s t-test. **<italic>p</italic>&lt;0.01; ***<italic>p</italic>&lt;0.001; ****<italic>p</italic>&lt;0.0001; ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="ffunb-06-1613244-g006.tif">
<alt-text content-type="machine-generated">Bar graphs labeled A, B, and C depict log CFU per mL for different conditions. Groups are &#x201c;Cau,&#x201d; &#x201c;Cau + Pa,&#x201d; &#x201c;Cal,&#x201d; and &#x201c;Cal + Pa,&#x201d; under RPMI, twice RPMI, RPMI with two percent glucose, or YPD. Significant differences marked as ****, with some comparisons marked &#x201c;ns&#x201d; for not significant. Each graph compares two conditions with similar trends, showing higher CFU in &#x201c;Cau&#x201d; and &#x201c;Cal&#x201d; groups compared to their &#x201c;+&#x201d; combinations in all contexts.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Iron partially restores <italic>C. auris</italic> growth in co-culture</title>
<p>The effect of iron supplementation on <italic>C. auris</italic> inhibition by <italic>P. aeruginosa</italic> was evaluated using RPMI medium supplemented with varying concentrations of FeSO<sub>4</sub>. Iron significantly alleviated the inhibitory effect at all tested concentrations, with no further improvement observed beyond 30 &#x3bc;M (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>). It is important to note that the growth of <italic>C. auris</italic> in monoculture also was substantially enhanced by FeSO<sub>4</sub> supplementation (statistical analysis not shown).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>FeSO<sub>4</sub> partially restores <italic>C</italic>. <italic>auris</italic> growth by reducing the inhibitory effect caused by <italic>P. aeruginosa</italic> (Pa). <bold>(A)</bold> Different concentrations of FeSO<sub>4</sub> (30, 120, 240, 480, 960, and 1920 &#x3bc;M) were tested; concentrations above 30 &#x3bc;M showed no additional effect on fungal growth restoration. <bold>(B)</bold> Significant reduction in growth arrest of <italic>C</italic>. <italic>auris</italic> in coculture for iron concentrations between 30 and 480 &#x3bc;M; however, higher concentrations (960 and 1920 &#x3bc;M) did not promote additional effects. Data are representative of three independent experiments. Statistical analysis was performed using ANOVA and Tukey&#x2019;s post-test. *<italic>p</italic>&lt;0.05; **<italic>p</italic>&lt;0.01; ***<italic>p</italic>&lt;0.001; ****<italic>p</italic>&lt;0.0001; ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="ffunb-06-1613244-g007.tif">
<alt-text content-type="machine-generated">Bar graphs showing the effects of different concentrations of FeSO&#x2084; on yeast growth and inhibition. Graph A compares log CFU/mL for &#x201c;Cau&#x201d; and &#x201c;Cau + Pa,&#x201d; indicating statistical significance with asterisks. Graph B shows percent inhibition of yeast growth in &#x201c;Cau + Pa&#x201d; vs. &#x201c;Cau,&#x201d; with significance annotated. Red bars represent &#x201c;Cau,&#x201d; purple bars represent &#x201c;Cau + Pa.&#x201d; Statistical annotations include non-significant (ns), and varying levels of significance up to p&lt;0.0001 (****).</alt-text>
</graphic>
</fig>
<p>To further confirm the impact of iron on the antagonistic effect of <italic>P. aeruginosa</italic> and to control for the growth enhancement caused by iron supplementation alone, we calculated the percentage of inhibition for each treatment by comparing <italic>C. auris</italic> growth in monoculture versus co-culture with <italic>P. aeruginosa</italic> in the presence and absence of FeSO<sub>4</sub> (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>). The results confirmed that iron concentrations between 30 and 480 &#x3bc;M significantly reduced growth inhibition, while higher concentrations did not produce additional benefits.</p>
<p>Overall, these findings indicate that Fe<sup>2+</sup> supplementation partially restores <italic>C. auris</italic> growth in co-culture with <italic>P. aeruginosa</italic> compared to monoculture conditions.</p>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>
<italic>P. aeruginosa</italic> cell-free supernatant (CFS) inhibits <italic>C. auris</italic> in a concentration-dependent manner</title>
<p>Since <italic>P. aeruginosa</italic> inhibits the growth of <italic>C. auris</italic> even in the absence of viable bacterial cells (spot-on-the-lawn assay), it is likely that the bacterium produces and secretes molecules with fungistatic activity. To investigate whether this inhibition is mediated by secreted compounds, cell-free supernatant (CFS) was obtained after 24 hours of <italic>P. aeruginosa</italic> growth and used to culture <italic>C. auris</italic> and <italic>C. albicans</italic>. Unlike in co-culture conditions, the crude CFS did not inhibit yeast growth (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>). Similarly, the growth of <italic>P. aeruginosa</italic> was unaffected when cultured in crude CFS derived from <italic>C. albicans</italic> or <italic>C. auris</italic> cultures (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>).</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>The cell-free supernatant (CFS) of <italic>P. aeruginosa</italic> did not inhibit <italic>Candida</italic> spp. growth unless concentrated. CFS from <italic>P. aeruginosa</italic> (Pa) cultured for 24 or 72 hours and CFS from <italic>P. aeruginosa</italic> co-cultured with <italic>C</italic>. <italic>auris</italic> did not significantly affect <italic>C</italic>. <italic>auris</italic> (Cau) growth <bold>(A)</bold>. In contrast, CFS from <italic>P. aeruginosa</italic> concentrated by lyophilization (lCFS<sub>(Pa)</sub>) inhibited the growth of both <italic>C</italic>. <italic>auris</italic> and <italic>C</italic>. <italic>albicans</italic>. <bold>(B)</bold> Representative images show fungal growth inhibition in RPMI (control), RPMI + lCFS<sub>(Pa)</sub>, and RPMI + lCFS<sub>(Pa)</sub> + FeSO<sub>4</sub>. <bold>(C)</bold> CFU/mL count of <italic>Candida</italic> spp. growth. <italic>Candida</italic> growth was reduced in RPMI + lCFS<sub>Pa</sub> compared to RPMI alone. Supplementation with higher concentrations of FeSO<sub>4</sub> (480 and 1920 &#x3bc;M) increased the growth in RPMI + lCFS<sub>(Pa)</sub>, although not to the same extent as in the control. Statistical analysis was performed using ANOVA followed by Tukey&#x2019;s post-test. **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001; ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="ffunb-06-1613244-g008.tif">
<alt-text content-type="machine-generated">Panel A shows a bar graph comparing the fungal load of Cau and Cau + CFS over different conditions, indicating no significant differences. Panel B displays a visual analysis of C. auris and C. albicans grown in varying concentrations of FeSO4, showing color changes. Panel C presents another bar graph illustrating the fungal load of both species under various treatments with significant differences noted.</alt-text>
</graphic>
</fig>
<p>The potential influence of bacterial culture duration before filtration was also evaluated. When <italic>P. aeruginosa</italic> was cultivated for an extended time (72 hours) before supernatant collection, the resulting CFS<sub>Pa</sub> also failed to inhibit <italic>Candida</italic> growth (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>). To test whether the presence of the yeast is required to trigger the production of antagonistic metabolites, a co-culture was established for 24 hours, and the resulting CFS<sub>(Cau + Pa)</sub> was subsequently used to culture <italic>C. auris</italic> for an additional 24 hours. Neither in this case was the growth of <italic>C. auris</italic> inhibited by the crude CFS<sub>(Cau + Pa)</sub> (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>).</p>
<p>The inhibitory effect of <italic>P. aeruginosa</italic> CFS on <italic>C. auris</italic> was reassessed using a 10-fold concentrated supernatant obtained by lyophilization (lCFS<sub>Pa</sub>). In 96-well plate assays, visual analysis confirmed that lCFS<sub>Pa</sub> completely inhibited <italic>C. auris</italic> growth (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>). After 72 hours of incubation, lCFS<sub>Pa</sub> effectively suppressed the yeast growth compared to RPMI alone, with similar inhibitory effects observed for <italic>C. albicans</italic> (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8B, C</bold>
</xref>).</p>
<p>To investigate the role of iron in modulating this interaction, lCFS<sub>Pa</sub> was reconstituted in RPMI and supplemented with FeSO<sub>4</sub>. At 30 &#x3bc;M, iron supplementation failed to reverse the inhibitory effect of lCFS<sub>Pa</sub>. However, higher concentrations (480 and 1920 &#x3bc;M) significantly increased yeast growth compared to cultures with lCFS<sub>Pa</sub> alone&#x2014;although not to the same extent as observed in the RPMI control medium (without lCFS<sub>Pa</sub>) (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8B, C</bold>
</xref>).</p>
<p>These findings confirm that <italic>P. aeruginosa</italic> secretes molecules with fungistatic activity against <italic>C. auris</italic> and <italic>C. albicans</italic>. Furthermore, this inhibitory effect is modulated by iron availability.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>
<italic>C. auris</italic> and <italic>P. aeruginosa</italic> are pathogens that have been extensively studied and are well known for their resistance to antimicrobials and disinfectants, as well as for their ability to persist in hospital environments and infect immunocompromised patients, particularly those receiving broad-spectrum antibiotic therapy (<xref ref-type="bibr" rid="B11">Du et&#xa0;al., 2020</xref>). Consequently, they are major contributors to HAIs.</p>
<p>Given their common characteristics, it is reasonable to hypothesize that these microorganisms may interact within a shared environment, potentially co-infecting or co-colonizing the same patient (<xref ref-type="bibr" rid="B18">Khan et&#xa0;al., 2020</xref>). Indeed, metagenomic studies of the skin microbiome of residents of a specialized mechanical ventilation unit revealed simultaneous colonization by <italic>C. auris</italic> and <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="B34">Proctor et&#xa0;al., 2021</xref>). Similarly, another study involving nursing home residents showed that the skin&#x2014;particularly the nostrils and inguinal folds&#x2014;served as a reservoir for <italic>C. auris</italic> and <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="B35">Proctor et&#xa0;al., 2025</xref>). These findings raise important questions about how these pathogens interact with each other and the host microenvironment.</p>
<p>In our study, two widely used techniques for <italic>in vitro</italic> research were employed to investigate the interaction between <italic>P. aeruginosa</italic> and <italic>C. auris</italic>: the spot-on-the-lawn assay and liquid medium co-culture. The spot-on-the-lawn method, initially introduced by <xref ref-type="bibr" rid="B17">Harris et&#xa0;al. (1989)</xref>, is commonly used to evaluate antagonistic activity between microorganisms (<xref ref-type="bibr" rid="B43">Sun et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B1">Acurcio et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B5">Bastos et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B33">Peres-Emidio et&#xa0;al., 2023</xref>). This technique measures the size of inhibition zones formed by substances produced by a bacterium. Before introducing a fungal species, the bacterium is inactivated using chloroform vapor, thus ensuring that the fungus interacts solely with the substances diffused in the medium, rather than with live bacterial cells. In contrast, the liquid co-culture method allows direct interaction between live microorganisms, enabling mutual sensing and physical contact.</p>
<p>Our results demonstrated that, regardless of the technique used, <italic>P. aeruginosa</italic> consistently suppressed <italic>C. auris</italic> growth, as it does with <italic>C. albicans</italic>. Moreover, this inhibitory effect was also observed across multiple <italic>C. auris</italic> strains, indicating a conserved interaction. The co-culture experiment also revealed that yeast growth inhibition began early (between 8 and 12 hours) and persisted for up to 72 hours. Upon contact with <italic>P. aeruginosa</italic>, <italic>C. auris</italic> cells appeared unable to proliferate but remained viable. This was confirmed by fluorescence microscopy, which showed that, although the number of <italic>C. auris</italic> cells during co-culture reduced to 36% compared to monoculture, about 97% remained viable even after 72 hours of co-cultivation with the bacterium. These results support the idea that <italic>P. aeruginosa</italic> probably induces a fungistatic effect against <italic>C. auris</italic>.</p>
<p>Several studies have described the interaction between <italic>P. aeruginosa</italic> and <italic>Candida</italic> spp. as generally antagonistic to the yeast species (<xref ref-type="bibr" rid="B2">Ader et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B22">Lindsay et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B13">Fourie and Pohl, 2019</xref>; <xref ref-type="bibr" rid="B31">Peres-Em&#xed;dio, 2020</xref>), aligning with the findings of this study. This antagonism may result from nutrient competition or the secretion of molecules that impair yeast growth (<xref ref-type="bibr" rid="B13">Fourie and Pohl, 2019</xref>).</p>
<p>To investigate the hypothesis that growth inhibition results from nutrient competition, co-cultivation assays were performed in various nutrient-rich media. However, inhibition levels remained relatively unchanged, suggesting that adding glucose or other nutrients does not alter the antagonistic effect. Besides, the spot-on-the-lawn assay demonstrated that <italic>C. auris</italic> growth was inhibited even in the absence of live bacterial cells, supporting the hypothesis that <italic>P. aeruginosa</italic> secretes compounds capable of suppressing fungal growth. This was further reinforced by experiments using concentrated (lyophilized) <italic>P. aeruginosa</italic> cell-free supernatant (lCFS), significantly reducing fungal proliferation when reconstituted in RPMI. In contrast, non-lyophilized CFS had no significant impact, indicating that the concentration of these secreted molecules is critical to achieving the antifungal effect against <italic>C. auris</italic>.</p>
<p>
<italic>P. aeruginosa</italic> is particularly known to inhibit <italic>C. albicans</italic> growth by sequestering iron through siderophores, whose production is upregulated in the presence of the yeast (<xref ref-type="bibr" rid="B12">Fourie et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B20">Kramer et&#xa0;al., 2020</xref>). Iron is an essential micronutrient for the growth and metabolism of many pathogens, serving as a cofactor in key metabolic processes (<xref ref-type="bibr" rid="B4">Bastos et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B35">Proctor et&#xa0;al., 2025</xref>), including oxidative phosphorylation and electron transport within the respiratory chain (<xref ref-type="bibr" rid="B8">Caza and Kronstad, 2013</xref>). Its significance is underscored by its universal necessity for the survival and proliferation of living organisms (<xref ref-type="bibr" rid="B13">Fourie and Pohl, 2019</xref>). <italic>P. aeruginosa</italic>, in particular, has a strong dependence of iron for its growth and efficiently competes with other organisms for it (<xref ref-type="bibr" rid="B49">Zhao and Yu, 2018</xref>). Moreover, <italic>P. aeruginosa</italic> PA14 produces metabolites that restrict iron uptake by other microorganisms, such as <italic>A. fumigatus</italic> (<xref ref-type="bibr" rid="B35">Proctor et&#xa0;al., 2025</xref>) and <italic>C. albicans</italic> (<xref ref-type="bibr" rid="B37">Rahme et&#xa0;al., 1997</xref>; <xref ref-type="bibr" rid="B15">Grainha et&#xa0;al., 2020</xref>).</p>
<p>In order to investigate whether a mechanism similar to that observed in <italic>C. albicans</italic> also applies to <italic>C. auris</italic>, co-cultivation and lCSF<sub>(Pa)</sub> inhibition assays were performed in RPMI medium supplemented with different concentrations of FeSO<sub>4</sub>. Supplementation reduced the inhibitory effect of <italic>P. aeruginosa</italic> or lCSF<sub>(Pa)</sub> on <italic>C. auris</italic>, although it was not sufficient to completely restore fungal growth. Notably, in the presence of lCFS<sub>(Pa)</sub>, growth restoration occurred in a dose-dependent manner relative to FeSO<sub>4</sub>.</p>
<p>These results are in line with findings reported by <xref ref-type="bibr" rid="B19">Kov&#xe1;cs et&#xa0;al. (2025)</xref>, who demonstrated that exposure of <italic>C. auris</italic> to N-(3-oxododecanoyl)-L-homoserine lactone (HSL)&#x2014;a key quorum-sensing molecule produced by <italic>P. aeruginosa</italic>&#x2014;inhibited fungal growth and altered gene expression. Specifically, HSL downregulated genes involved in iron homeostasis, potentially leading to reduced intracellular iron levels in <italic>C. auris</italic>. These data support the hypothesis that <italic>P. aeruginosa</italic> secretes factors capable of disrupting iron metabolism in <italic>C. auris</italic>, thereby contributing to growth inhibition (<xref ref-type="bibr" rid="B2">Ader et&#xa0;al., 2008</xref>). Additionally, another study reported that <italic>P. aeruginosa</italic> produces other molecules with anti-<italic>C. auris</italic> activity, such as fluopsin C (<xref ref-type="bibr" rid="B42">Spoladori et&#xa0;al., 2023</xref>), a broad-spectrum antibiotic that contains a copper ion chelated by two thiohydroxamate groups (<xref ref-type="bibr" rid="B29">Patteson et&#xa0;al., 2021</xref>). While the exact mechanism of fluopsin C against <italic>C. auris</italic> remains unclear, it may also interfere with ion homeostasis (<xref ref-type="bibr" rid="B42">Spoladori et&#xa0;al., 2023</xref>), further impairing yeast growth.</p>
<p>Although iron plays a crucial role in restoring the growth capacity of <italic>C. auris</italic>, other extracellular factors produced by <italic>P. aeruginosa</italic> may also contribute to the antifungal effect. For example, phenazines, such as pyocyanin, are toxic to fungi and other eukaryotes due to their redox-active properties, which can induce the formation of reactive oxygen species (ROS) (<xref ref-type="bibr" rid="B28">Mudaliar and Prasad, 2024</xref>). Additionally, rhamnolipids might be involved in the inhibitory effect, as they are known to suppress &#x3b2;-1,3-glucan synthase, an important enzyme involved in the biosynthesis of fungal cell walls (<xref ref-type="bibr" rid="B6">Briard et&#xa0;al., 2017</xref>). Further experiments are needed to elucidate the precise mechanisms through which <italic>P. aeruginosa</italic> inhibits <italic>C. auris</italic>.</p>
<p>In conclusion, our results demonstrates that <italic>P. aeruginosa</italic> exhibits a significant ability to inhibit <italic>C. auris</italic> growth, similar to its effect on <italic>C. albicans</italic>. This inhibitory activity does not seem to depend on the inoculum size and incubation time, pointing to a fungistatic mechanism consistent across different culture media. The inhibition is likely mediated by chemical substances secreted by <italic>P. aeruginosa</italic>, and iron availability emerges as a contributing factor in modulating this interaction.</p>
<p>Furthermore, our study highlight the potential of substances secreted by <italic>P. aeruginosa</italic> as antifungal agents against <italic>C. auris</italic>, contingent upon their concentration. Our results provide a foundation for future research to elucidate the chemical composition and mechanisms of action of these bioactive compounds. Furthermore, they contribute to a broader understanding of microbial interactions and their potential implications for hosts during co-colonization or infection.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <uri xlink:href="https://repositorio.ufrn.br/bitstream/123456789/60104/1/Interacaometabolicaentrefungo_Macedo_2024.pdf">https://repositorio.ufrn.br/bitstream/123456789/60104/1/Interacaometabolicaentrefungo_Macedo_2024.pdf</uri>.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>AM: Writing &#x2013; review &amp; editing, Investigation, Writing &#x2013; original draft. DS: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing, Investigation. AM: Investigation, Writing &#x2013; review &amp; editing. GF: Writing &#x2013; review &amp; editing, Investigation. MS: Writing &#x2013; review &amp; editing, Investigation. KI: Writing &#x2013; review &amp; editing, Resources, Supervision. NP: Supervision, Writing &#x2013; review &amp; editing, Resources. DS: Writing &#x2013; review &amp; editing, Supervision, Resources. LR: Writing &#x2013; review &amp; editing, Resources, Supervision. GG: Supervision, Writing &#x2013; review &amp; editing, Resources. RB: Writing &#x2013; original draft, Project administration, Methodology, Writing &#x2013; review &amp; editing, Conceptualization, Supervision.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This research was funded by Conselho Nacional de Desenvolvimento Cient&#xed;fico e Tecnol&#xf3;gico&#x2014;CNPq and Brazilian Ministry of Health (408540/2022&#x2013;2 and 444501/2023-1), the National Institute of Science and Technology (INCT) Funvir from Brazil (grant number 405934/2022) and the Coordena&#xe7;&#xe3;o de Aperfei&#xe7;oamento de Pessoal de Nivel Superior&#x2014;Brazil (CAPES)&#x2014;Financing Code 001.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that Generative AI was used in the creation of this manuscript. During the preparation of this work the authors used ChatGPT&#x2014;OpenAI to improve the language. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Acurcio</surname> <given-names>L. B.</given-names>
</name>
<name>
<surname>Wuyts</surname> <given-names>S.</given-names>
</name>
<name>
<surname>de Cicco Sandes</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Sant&#x2019;anna</surname> <given-names>F. M.</given-names>
</name>
<name>
<surname>Pedroso</surname> <given-names>S. H. S. P.</given-names>
</name>
<name>
<surname>Bastos</surname> <given-names>R. W.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Milk fermented by Lactobacillus paracasei NCC 2461 (ST11) modulates the immune response and microbiota to exert its protective effects against Salmonella Typhimurium infection in mice</article-title>. <source>Probiotics Antimicrob. Proteins.</source> <volume>12</volume>, <fpage>1398</fpage>&#x2013;<lpage>1408</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12602-020-09634-x</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ader</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Faure</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Guery</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Nseir</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>
<italic>Pseudomonas aeruginosa</italic> and <italic>Candida albicans</italic> interaction in the respiratory tract: from pathophysiology to a therapeutic perspective</article-title>. <source>Pathol. Biol. (Paris).</source> <volume>56</volume>, <fpage>164</fpage>&#x2013;<lpage>169</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.patbio.2007.06.002</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alanio</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Garcia-Hermoso</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Grenouillet</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Bellanger</surname> <given-names>A. P.</given-names>
</name>
<name>
<surname>Millon</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Bretagne</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>First patient-to-patient intrahospital transmission of Clade I Candida auris in France revealed after a two-month incubation period</article-title>. <source>Microbiol. Spectr.</source> <volume>10</volume>, <fpage>e01833</fpage>&#x2013;<lpage>e01822</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/spectrum.01833-22</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bastos</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Valero</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>L. P.</given-names>
</name>
<name>
<surname>Schoen</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Drott</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Brauer</surname> <given-names>V.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Functional characterization of clinical isolates of the opportunistic fungal pathogen Aspergillus nidulans</article-title>. <source>mSphere</source> <volume>5</volume>, <fpage>e00153</fpage>&#x2013;<lpage>e00120</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mSphere.00153-20</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bastos</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Valero</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>L. P.</given-names>
</name>
<name>
<surname>Schoen</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Drott</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Brauer</surname> <given-names>V.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation</article-title>. <source>mBio.</source> <volume>13</volume>, <fpage>e01850</fpage>&#x2013;<lpage>e01822</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mbio.01850-22</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Briard</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Rasoldier</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Bomme</surname> <given-names>P.</given-names>
</name>
<name>
<surname>ElAouad</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Guerreiro</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Chassagne</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Dirhamnolipids secreted from Pseudomonas aeruginosa modify antifungal susceptibility of <italic>Aspergillus fumigatus</italic> by inhibiting &#x3b2;-1,3-glucan synthase activity</article-title>. <source>ISME J.</source> <volume>11</volume>, <fpage>1578</fpage>&#x2013;<lpage>1591</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ismej.2017.32</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calvo</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Melo</surname> <given-names>A. S. A.</given-names>
</name>
<name>
<surname>Perozo-Mena</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hagen</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Meis</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Colombo</surname> <given-names>A. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia</article-title>. <source>J. Infect.</source> <volume>73</volume>, <fpage>369</fpage>&#x2013;<lpage>374</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jinf.2016.07.008</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caza</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kronstad</surname> <given-names>J. W.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Shared and distinct mechanisms of iron acquisition by bacterial and fungal pathogens of humans</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>3</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2013.00080</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>d&#x2019;Enfert</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Kaune</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Alaban</surname> <given-names>L. R.</given-names>
</name>
<name>
<surname>Chakraborty</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Cole</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Delavy</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>The impact of the fungus-host-microbiota interplay upon Candida albicans infections: current knowledge and new perspectives</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>45</volume>, <elocation-id>fuaa060</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/femsre/fuaa060</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Didik</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Yau</surname> <given-names>A. P.</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>H. L.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>N. H.</given-names>
</name>
<name>
<surname>Wah</surname> <given-names>Y. T.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Long-range air dispersion of Candida auris in a cardiothoracic unit outbreak in Hong Kong</article-title>. <source>J. Hosp Infect.</source> <volume>142</volume>, <fpage>105</fpage>&#x2013;<lpage>114</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jhin.2023.09.019</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Bing</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ennis</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Nobile</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Candida auris: epidemiology, biology, antifungal resistance, and virulence</article-title>. <source>PloS Pathog.</source> <volume>16</volume>, <elocation-id>e1008921</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fourie</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ells</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Swart</surname> <given-names>C. W.</given-names>
</name>
<name>
<surname>Sebolai</surname> <given-names>O. M.</given-names>
</name>
<name>
<surname>Albertyn</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Pohl</surname> <given-names>C. H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Candida albicans and Pseudomonas aeruginosa interaction, with focus on the role of eicosanoids</article-title>. <source>Front. Physiol.</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphys.2016.00064</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fourie</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Pohl</surname> <given-names>C. H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Beyond antagonism: the interaction between Candida species and Pseudomonas aeruginosa</article-title>. <source>J. Fungi</source> <volume>5</volume>, <elocation-id>34</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/jof5020034</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Govender</surname> <given-names>N. P.</given-names>
</name>
<name>
<surname>Magobo</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Mpembe</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Mhlanga</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Matlapeng</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Corcoran</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Candida auris in South Africa, 2012&#x2013;2016</article-title>. <source>Emerg. Infect. Dis.</source> <volume>24</volume>, <fpage>2036</fpage>&#x2013;<lpage>2040</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3201/eid2411.180368</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grainha</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Jorge</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Lopes</surname> <given-names>S. P.</given-names>
</name>
<name>
<surname>Louren&#xe7;o</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Nogueira</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>M. O.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Unravelling Pseudomonas aeruginosa and Candida albicans communication in coinfection scenarios: insights through network analysis</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2020.550505</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenberg</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Hua</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Nelson</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ouyang</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Ethanol inhibits lung clearance of Pseudomonas aeruginosa by a neutrophil and nitric oxide-dependent mechanism, in <italic>vivo</italic>
</article-title>. <source>Alcohol Clin. Exp. Res.</source> <volume>23</volume>, <fpage>735</fpage>&#x2013;<lpage>744</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00000374-199904001-00021</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname> <given-names>L. J.</given-names>
</name>
<name>
<surname>Daeschel</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Stiles</surname> <given-names>M. E.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Antimicrobial activity of lactic acid bacteria against Listeria monocytogenes</article-title>. <source>J. Food Prot</source> <volume>52</volume>, <fpage>384</fpage>&#x2013;<lpage>387</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4315/0362-028X-52.6.384</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Ahmad</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Musarrat</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Al-Khedhairy</surname> <given-names>A. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Virulence and biofilms as promising targets in developing antipathogenic drugs against candidiasis</article-title>. <source>Future Sci. OA.</source> <volume>6</volume>, <fpage>FSO440</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2144/fsoa-2019-0027</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kov&#xe1;cs</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Jakab</surname> <given-names>&#xc1;.</given-names>
</name>
<name>
<surname>Balla</surname> <given-names>N.</given-names>
</name>
<name>
<surname>T&#xf3;th</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Bal&#xe1;zsi</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Forg&#xe1;cs</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2025</year>). <article-title>A comprehensive analysis of the effect of quorum-sensing molecule 3-oxo-C12-homoserine lactone on Candida auris and Candida albicans</article-title>. <source>Biofilm</source> <volume>9</volume>, <elocation-id>100259</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bioflm.2025.100259</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname> <given-names>J.</given-names>
</name>
<name>
<surname>&#xd6;zkaya</surname> <given-names>&#xd6;.</given-names>
</name>
<name>
<surname>K&#xfc;mmerli</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Bacterial siderophores in community and host interactions</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>18</volume>, <fpage>152</fpage>&#x2013;<lpage>163</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41579-019-0284-4</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>W. G.</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Uh</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Kin</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>K. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>First three reported cases of nosocomial fungemia caused by Candida auris</article-title>. <source>J. Clin. Microbiol.</source> <volume>49</volume>, <fpage>3139</fpage>&#x2013;<lpage>3142</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JCM.00319-11</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindsay</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Morales</surname> <given-names>D. K.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Grahl</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Willger</surname> <given-names>S. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Analysis of Candida albicans mutants defective in the Cdk8 module of mediator reveal links between metabolism and biofilm formation</article-title>. <source>PloS Genet.</source> <volume>10</volume>, <elocation-id>e1004567</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pgen.1004567</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lockhart</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Etienne</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Vallabhaneni</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Farooqi</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Chowdhary</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Govender</surname> <given-names>N. P.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses</article-title>. <source>Clin. Infect. Dis.</source> <volume>64</volume>, <fpage>134</fpage>&#x2013;<lpage>140</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cid/ciw691</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magobo</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Corcoran</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Seetharam</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Govender</surname> <given-names>N. P.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>
<italic>Candida auris</italic>&#x2013;associated candidemia, South Africa</article-title>. <source>Emerg. Infect. Dis.</source> <volume>20</volume>, <page-range>7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3201/eid2007.131765</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mielko</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Jab&#x142;o&#x144;ska</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Milczewska</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sands</surname> <given-names>D.</given-names>
</name>
<name>
<surname>&#x141;ukaszewicz</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Pi&#x105;tkowska</surname> <given-names>E.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Metabolomic studies of P. aeruginosa</article-title>. <source>World J. Microbiol. Biotechnol.</source> <volume>35</volume>, <fpage>178</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11274-019-2739-1</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikkelsen</surname> <given-names>H.</given-names>
</name>
<name>
<surname>McMullan</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Filloux</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The <italic>Pseudomonas aeruginosa</italic> reference strain displays increased virulence due to a mutation in ladS</article-title>. <source>PloS One</source> <volume>6</volume>, <elocation-id>e29113</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0029113</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morales</surname> <given-names>D. K.</given-names>
</name>
<name>
<surname>Grahl</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Okegbe</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Dietrich</surname> <given-names>L. E.</given-names>
</name>
<name>
<surname>Jacobs</surname> <given-names>N. J.</given-names>
</name>
<name>
<surname>Hogan</surname> <given-names>D. A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Control of Candida albicans metabolism and biofilm formation by Pseudomonas aeruginosa phenazines</article-title>. <source>mBio.</source> <volume>4</volume>, <fpage>e00526</fpage>&#x2013;<lpage>e00512</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.00526-12</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mudaliar</surname> <given-names>S. B.</given-names>
</name>
<name>
<surname>Prasad</surname> <given-names>A. B.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>A biomedical perspective of pyocyanin from <italic>Pseudomonas aeruginosa</italic>: its applications and challenges</article-title>. <source>World J. Microbiol. Biotechnol.</source> <volume>40</volume>, <fpage>90</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11274-024-03889-0</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patteson</surname> <given-names>J. B.</given-names>
</name>
<name>
<surname>Putz</surname> <given-names>A. T.</given-names>
</name>
<name>
<surname>Tao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Simke</surname> <given-names>W. C.</given-names>
</name>
<name>
<surname>Bryant</surname> <given-names>L. H.</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Britt</surname> <given-names>R. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Biosynthesis of fluopsin C, a copper-containing antibiotic from Pseudomonas aeruginosa</article-title>. <source>Science</source> <volume>374</volume>, <fpage>1005</fpage>&#x2013;<lpage>1009</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.abj6749</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peleg</surname> <given-names>A. Y.</given-names>
</name>
<name>
<surname>Hogan</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Mylonakis</surname> <given-names>E.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Medically important bacterial&#x2013;fungal interactions</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>8</volume>, <fpage>340</fpage>&#x2013;<lpage>349</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro2313</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="thesis">
<person-group person-group-type="author">
<name>
<surname>Peres-Em&#xed;dio</surname> <given-names>E. C.</given-names>
</name>
</person-group> (<year>2020</year>). <source>Study of the interaction between three different kingdoms: understanding the complexity of coinfections between bacteria and the fungus Cryptococcus gattii in a murine model</source>. <publisher-name>Universidade Federal de Minas Gerais</publisher-name>, <publisher-loc>Belo Horizonte</publisher-loc>.</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peres-Emidio</surname> <given-names>E. C.</given-names>
</name>
<name>
<surname>Singulani</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Freitas</surname> <given-names>G. J. C.</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Gouveia-Eufrasio</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Carmo</surname> <given-names>P. H. F.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>P. aeruginosa infection modulates the immune response and increases mice resistance to Cryptococcus gattii</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.811474</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peres-Emidio</surname> <given-names>E. C.</given-names>
</name>
<name>
<surname>Singulani</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Freitas</surname> <given-names>G. J. C.</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Gouveia-Eufrasio</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Carmo</surname> <given-names>P. H. F.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Staphylococcus aureus triggers a protective inflammatory response against secondary Cryptococcus gattii infection in a murine model</article-title>. <source>Microbes Infect.</source> <volume>25</volume>, <elocation-id>105122</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micinf.2023.105122</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proctor</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Dangana</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Sexton</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Fukuda</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Yelin</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Stanley</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility</article-title>. <source>Nat. Med.</source> <volume>27</volume>, <fpage>1401</fpage>&#x2013;<lpage>1409</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41591-021-01383-w</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proctor</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Sansom</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>Deming</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Conlan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Blaustein</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Atkins</surname> <given-names>T. K.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Clonal Candida auris and ESKAPE pathogens on the skin of residents of nursing homes</article-title>. <source>Nature.</source> <volume>639</volume>, <fpage>1016</fpage>&#x2013;<lpage>1023</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-025-08608-9</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purschke</surname> <given-names>F. G.</given-names>
</name>
<name>
<surname>Hiller</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Trick</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Rupp</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Flexible survival strategies of Pseudomonas aeruginosa in biofilms result in increased fitness compared with Candida albicans</article-title>. <source>Mol. Cell Proteomics</source> <volume>11</volume>, <fpage>1652</fpage>&#x2013;<lpage>1669</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/mcp.M112.017673</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahme</surname> <given-names>L. G.</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>M. W.</given-names>
</name>
<name>
<surname>Le</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Tompkins</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>S. C. B.</given-names>
</name>
<etal/>
</person-group>. (<year>1997</year>). <article-title>Use of model plant hosts to identify <italic>pseudomonas aeruginosa</italic> virulence factors</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>94</volume>, <fpage>13245</fpage>&#x2013;<lpage>13250</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.94.24.13245</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruiz-Gait&#xe1;n</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Moret</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Tasias-Pitarch</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Aleixandre-L&#xf3;pez</surname> <given-names>A. I.</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Morel</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Calabuig</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>An outbreak due to <italic>Candida auris</italic> with prolonged colonisation and candidaemia in a tertiary care European hospital</article-title>. <source>Mycoses.</source> <volume>61</volume>, <fpage>498</fpage>&#x2013;<lpage>505</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/myc.12781</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saliba</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Nascimento</surname> <given-names>D. O.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>M. C. A.</given-names>
</name>
<name>
<surname>Assis</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Grayer</surname> <given-names>C. R. M.</given-names>
</name>
<name>
<surname>Raymond</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Eicosanoid-mediated proinflammatory activity of <italic>Pseudomonas aeruginosa</italic> ExoU</article-title>. <source>Cell Microbiol.</source> <volume>7</volume>, <fpage>1811</fpage>&#x2013;<lpage>1822</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00635.x</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satoh</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Makimura</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hasumi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Nishiyama</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Uchida</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Yamaguchi</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>
<italic>Candida auris</italic> sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital</article-title>. <source>Microbiol. Immunol.</source> <volume>53</volume>, <fpage>41</fpage>&#x2013;<lpage>44</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1348-0421.2008.00083.x</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schelenz</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hagen</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Rhodes</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Abdolrasouli</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Chowdhary</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hall</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>First hospital outbreak of the globally emerging Candida auris in a European hospital</article-title>. <source>Antimicrob. Resist. Infect. Control.</source> <volume>5</volume>, <fpage>35</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13756-016-0132-5</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spoladori</surname> <given-names>L. F. A.</given-names>
</name>
<name>
<surname>Andriani</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>I. M.</given-names>
</name>
<name>
<surname>Suzukawa</surname> <given-names>H. T.</given-names>
</name>
<name>
<surname>Gimenes</surname> <given-names>A. C. R.</given-names>
</name>
<name>
<surname>Bartolomeu-Gon&#xe7;alves</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Synergistic antifungal interaction between Pseudomonas aeruginosa LV strain metabolites and biogenic silver nanoparticles against Candida auris</article-title>. <source>Antibiotics (Basel)</source> <volume>12</volume>, <elocation-id>861</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antibiotics12050861</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>Q.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>
<italic>Candida albicans</italic> Amphotericin B-tolerant persister formation is closely related to surface adhesion</article-title>. <source>Mycopathologia</source> <volume>181</volume>, <fpage>41</fpage>&#x2013;<lpage>49</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11046-015-9894-1</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thi</surname> <given-names>M. T. T.</given-names>
</name>
<name>
<surname>Wibowo</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Rehm</surname> <given-names>B. H. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>P. aeruginosa biofilms</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume>, <elocation-id>8671</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms21228671</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trejo-Hern&#xe1;ndez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Andrade-Dom&#xed;nguez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Encarnaci&#xf3;n</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Interspecies competition triggers virulence and mutability in Candida albicans &#x2013; Pseudomonas aeruginosa mixed biofilms</article-title>. <source>ISME J.</source> <volume>8</volume>, <fpage>1974</fpage>&#x2013;<lpage>1988</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ismej.2014.53</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wettstadt</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>T. E.</given-names>
</name>
<name>
<surname>Fecht</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Filloux</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Delivery of the <italic>pseudomonas aeruginosa</italic> phospholipase effectors PldA and PldB in a VgrG- and H2-T6SS-dependent manner</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2019.01718</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="web">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group> (<year>2022</year>). <source>WHO fungal priority pathogens list to guide research, development and public health action</source> (<publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>). Available online at: <uri xlink:href="https://www.who.int/publications/i/item/9789240060241">https://www.who.int/publications/i/item/9789240060241</uri>.</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yadav</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>van Haren</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>A.</given-names>
</name>
<name>
<surname>de Groot</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Colonisation and transmission dynamics of Candida auris among chronic respiratory diseases patients hospitalised in a chest hospital, Delhi, India: a comparative analysis of whole genome sequencing and microsatellite typing</article-title>. <source>J. Fungi (Basel).</source> <volume>7</volume>, <elocation-id>81</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/jof7020081</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis</article-title>. <source>PeerJ.</source> <volume>6</volume>, <elocation-id>e5931</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7717/peerj.5931</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>